Literature DB >> 3547408

DNA rearrangements in human follicular lymphoma can involve the 5' or the 3' region of the bcl-2 gene.

Y Tsujimoto, M M Bashir, I Givol, J Cossman, E Jaffe, C M Croce.   

Abstract

In most human follicular lymphomas, the chromosome translocation t(14;18) occurs within two breakpoint clustering regions on chromosome 18, the major one at the 3' untranslated region of the bcl-2 gene and the minor one at 3' of the gene. Analysis of a panel of follicular lymphoma DNAs using probes for the first exon of the bcl-2 gene indicates that DNA rearrangements may also occur 5' to the involved bcl-2 gene. In this case the IgH locus and the bcl-2 gene are found in the order 3' C gamma S gamma/mu JH 5'::5' bcl-2 3' (where C = constant, S = switch, and JH = joining segment of the heavy chain locus), suggesting that an inversion also occurred during the translocation process. The coding regions of the bcl-2 gene, however, are left intact in all cases of follicular lymphoma studied to date.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3547408      PMCID: PMC304421          DOI: 10.1073/pnas.84.5.1329

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  15 in total

1.  Detection of specific sequences among DNA fragments separated by gel electrophoresis.

Authors:  E M Southern
Journal:  J Mol Biol       Date:  1975-11-05       Impact factor: 5.469

2.  Chromosome abnormalities in poorly differentiated lymphocytic lymphoma.

Authors:  S Fukuhara; J D Rowley; D Variakojis; H M Golomb
Journal:  Cancer Res       Date:  1979-08       Impact factor: 12.701

3.  Structure of the human immunoglobulin mu locus: characterization of embryonic and rearranged J and D genes.

Authors:  J V Ravetch; U Siebenlist; S Korsmeyer; T Waldmann; P Leder
Journal:  Cell       Date:  1981-12       Impact factor: 41.582

4.  Insertion of N regions into heavy-chain genes is correlated with expression of terminal deoxytransferase in B cells.

Authors:  S V Desiderio; G D Yancopoulos; M Paskind; E Thomas; M A Boss; N Landau; F W Alt; D Baltimore
Journal:  Nature       Date:  1984 Oct 25-31       Impact factor: 49.962

5.  Cloning of the chromosome breakpoint of neoplastic B cells with the t(14;18) chromosome translocation.

Authors:  Y Tsujimoto; L R Finger; J Yunis; P C Nowell; C M Croce
Journal:  Science       Date:  1984-11-30       Impact factor: 47.728

Review 6.  Molecular basis of human B cell neoplasia.

Authors:  C M Croce; P C Nowell
Journal:  Blood       Date:  1985-01       Impact factor: 22.113

7.  Translocation of immunoglobulin VH genes in Burkitt lymphoma.

Authors:  J Erikson; J Finan; P C Nowell; C M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  1982-09       Impact factor: 11.205

8.  Distinctive chromosomal abnormalities in histologic subtypes of non-Hodgkin's lymphoma.

Authors:  J J Yunis; M M Oken; M E Kaplan; K M Ensrud; R R Howe; A Theologides
Journal:  N Engl J Med       Date:  1982-11-11       Impact factor: 91.245

9.  Repression of rearranged mu gene and translocated c-myc in mouse 3T3 cells X Burkitt lymphoma cell hybrids.

Authors:  K Nishikura; A ar-Rushdi; J Erikson; E DeJesus; D Dugan; C M Croce
Journal:  Science       Date:  1984-04-27       Impact factor: 47.728

10.  Involvement of the bcl-2 gene in human follicular lymphoma.

Authors:  Y Tsujimoto; J Cossman; E Jaffe; C M Croce
Journal:  Science       Date:  1985-06-21       Impact factor: 47.728

View more
  27 in total

1.  Antiapoptotic herpesvirus Bcl-2 homologs escape caspase-mediated conversion to proapoptotic proteins.

Authors:  D S Bellows; B N Chau; P Lee; Y Lazebnik; W H Burns; J M Hardwick
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

2.  Inverse transposition by the RAG1 and RAG2 proteins: role reversal of donor and target DNA.

Authors:  I-hung Shih; Meni Melek; Nadeesha D Jayaratne; Martin Gellert
Journal:  EMBO J       Date:  2002-12-02       Impact factor: 11.598

3.  The detection of t(14;18) in archival lymph nodes: development of a fluorescence in situ hybridization (FISH)-based method and evaluation by comparison with polymerase chain reaction.

Authors:  Sharon L Barrans; Paul A S Evans; Sheila J M O'Connor; Roger G Owen; Gareth J Morgan; Andrew S Jack
Journal:  J Mol Diagn       Date:  2003-08       Impact factor: 5.568

4.  Proto-oncogene analysis in multiple myeloma.

Authors:  M Ladanyi; S Wang; R Niesvizky; H Feiner; J Michaeli
Journal:  Am J Pathol       Date:  1992-10       Impact factor: 4.307

Review 5.  The molecular biology of B-cell lymphoma: clinicopathologic implications.

Authors:  P M Kluin; J H van Krieken
Journal:  Ann Hematol       Date:  1991-04       Impact factor: 3.673

6.  Rapid method for distinguishing clonal from polyclonal B cell populations in surgical biopsy specimens.

Authors:  K P McCarthy; J P Sloane; L M Wiedemann
Journal:  J Clin Pathol       Date:  1990-05       Impact factor: 3.411

7.  Molecular characterization of IgA- and/or IgG-switched chronic lymphocytic leukemia B cells.

Authors:  A Matolcsy; P Casali; R G Nádor; Y F Liu; D M Knowles
Journal:  Blood       Date:  1997-03-01       Impact factor: 22.113

8.  A Bcl-2 homolog encoded by Kaposi sarcoma-associated virus, human herpesvirus 8, inhibits apoptosis but does not heterodimerize with Bax or Bak.

Authors:  E H Cheng; J Nicholas; D S Bellows; G S Hayward; H G Guo; M S Reitz; J M Hardwick
Journal:  Proc Natl Acad Sci U S A       Date:  1997-01-21       Impact factor: 11.205

9.  Variant translocation of the bcl-2 gene to immunoglobulin lambda light chain gene in chronic lymphocytic leukemia.

Authors:  M Adachi; J Cossman; D Longo; C M Croce; Y Tsujimoto
Journal:  Proc Natl Acad Sci U S A       Date:  1989-04       Impact factor: 11.205

10.  Evolution of B-cell malignancy: pre-B-cell leukemia resulting from MYC activation in a B-cell neoplasm with a rearranged BCL2 gene.

Authors:  C E Gauwerky; F G Haluska; Y Tsujimoto; P C Nowell; C M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  1988-11       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.